...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.
【24h】

Use of health insurance claim patterns to identify patients using nonsteroidal anti-inflammatory drugs for rheumatoid arthritis.

机译:使用健康保险索赔模式来识别使用类固醇消炎药治疗类风湿关节炎的患者。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To determine healthcare claim patterns associated using nonsteroidal anti-inflammatory drugs (NSAIDs) for rheumatoid arthritis (RA). METHODS: The CADEUS study randomly identified NSAID users within the French health insurance database. One-year claims data were extracted, and NSAID indication was obtained from prescribers. Logistic regression was used in a development sample to identify claim patterns predictive of RA and models applied to a validation sample. Analyses were stratified on the dispensation of immunosuppressive agents or specific antirheumatism treatment, and the area under the receiver operating characteristic curve was used to estimate discriminant power. RESULTS: NSAID indication was provided for 26?259 of the 45?217 patients included in the CADEUS cohort; it was RA for 956 patients. Two models were constructed using the development sample (n?=?13?143), stratifying on the dispensation of an immunosuppressive agent or specific antirheumatism treatment. Discriminant power was high for both models (AUC?>?0.80) and was not statistically different from that found when applied to the validation sample (n?=?13?116). CONCLUSIONS: The models derived from this study may help to identify patients prescribed NSAIDs who are likely to have RA in claims databases without medical data such as treatment indication. Copyright ? 2012 John Wiley & Sons, Ltd.
机译:目的:确定使用类固醇消炎药(NSAIDs)治疗类风湿关节炎(RA)相关的医疗保健要求模式。方法:CADEUS研究在法国健康保险数据库中随机识别了NSAID用户。提取一年期索赔数据,并从处方者处获得NSAID适应症。在开发样本中使用Logistic回归来识别可预测RA的索赔模式以及应用于验证样本的模型。对免疫抑制剂的分配或特定的风湿病治疗进行了分层分析,并使用接受者工作特征曲线下的面积来估计判别力。结果:CADEUS队列中的45〜217例患者中有26〜259例提供了NSAID适应症; 956例患者为RA。使用显影样品(n≥13≤143)构建了两个模型,对免疫抑制剂或特异性抗风湿病的治疗进行了分层。两种模型的判别力均很高(AUC≥0.80),与应用于验证样本时的判别力无统计学差异(n≥13≤116)。结论:本研究得出的模型可能有助于在没有医疗数据(如治疗指征)的理赔数据库中识别出可能患有类风湿关节炎的处方NSAID患者。版权? 2012年John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号